Abbott's FreeStyle Libre Pro Flash Glucose Monitoring System is intended for use in the professional setting to help patients with diabetes and clinicians manage the disease. The clinician places the small sensor, which can stay in place for up to two weeks, on the back of the patient's upper arm. The sensor measures interstitial glucose continuously and captures readings at 15-minute increments. After the two-week period, the clinician sees the patient again, scans the sensor, and downloads the glucose readings.
Abbott announced approval of FreeStyle Libre Pro in India in April 2015. A version of the technology intended to be used for self-management by patients received CE Mark in September 2014.
The company also submitted for FDA approval of the FreeStyle Libre Pro in the second quarter of 2015, making a 2016 appearance a possibility.
These products do not have U.S. FDA regulatory clearance or approval as of January 22, 2016.
[Image courtesy of ABBOTT]
|Check out the future of medical technology at the world's largest medical design and manufacturing event—register for the MD&M West Conference, February 9-11, 2016.|